Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Synthetic Biologists Create Interlinked Microbial Populations

By LabMedica International staff writers
Posted on 09 Sep 2015
A team of synthetic biologists has demonstrated a method for controlling how populations of microbial cells interact and regulate each other.

A challenge of synthetic biology is the creation of cooperative microbial systems that exhibit population-level behaviors. More...
Such systems use cellular signaling mechanisms to regulate gene expression across multiple cell types.

In an attempt to create such a system artificially, investigators at Rice University (Houston, TX, USA) constructed a synthetic microbial consortium from genetically engineered populations of E. coli that comprised two distinct cell types—an “activator” strain and a “repressor” strain. The activator strain upregulated the expression of targeted genes while the repressor strain downregulated the same genes. The bacteria, which were grown in microfluidic culture devices, had been engineered to synthesize fluorescent reporter genes so their activities could be monitored.

Results published in the August 28, 2015, issue of the journal Science revealed that the strains produced two orthogonal cell-signaling molecules that regulated gene expression within a synthetic circuit spanning both strains. Of particular interest was the observation that the two strains generated emergent, population-level oscillations only when cultured together.

"The main push in synthetic biology has been to engineer single cells," said senior author Dr. Matthew R. Bennett, assistant professor of biochemistry and cell biology at Rice University. "But now we are moving toward multicellular systems. We want cells to coordinate their behaviors in order to elicit a populational response, just the way our bodies do. We have many different types of cells in our bodies, from skin cells to liver cells to pancreatic cells, and they all coordinate their behaviors to make us work properly. To do this, they often send out small signaling molecules that are produced in one cell type and effect change in another cell type. We take that principle and engineer it into these very simple organisms to see if we can understand and build multicellular systems from the ground up."

Related Links:

Rice University



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.